From Yahoo Finance: 2025-04-02 09:10:00

Proxy adviser ISS recommends Pfizer investors reject executive compensation proposal due to concerns about changes to long-term awards to CEO and lack of clarity on pipeline goals. Annual incentives tied to financial goals, with potential 30% variation based on pipeline and ESG goals achieved. Pfizer defends program, facing pressure to improve performance. Pfizer shareholders to vote on proposal at annual meeting.



Read more at Yahoo Finance: Proxy adviser ISS recommends against Pfizer executive pay proposal